Literature DB >> 15904446

Presenting symptoms of epithelial ovarian cancer.

Isam Lataifeh1, Donald E Marsden, Greg Robertson, Val Gebski, Neville F Hacker.   

Abstract

OBJECTIVES: Epithelial ovarian cancer is a common disease with a high mortality, the latter being frequently attributed to late diagnosis due to failure to recognise symptoms of early disease. This study was designed to determine any differences in symptomatology between patients with early and advanced stage disease.
DESIGN: A retrospective cohort study of 100 patients with stage 1 disease and 100 with stage 3 disease. Ten consecutive patients with stage 1 disease and 10 with stage 3 disease were identified from the database of patients treated each year from 1990 to 1999.
SETTING: A tertiary referral centre for gynecological malignancy. OUTCOME MEASURES: The nature and duration of symptoms, age at presentation, and the size, histologic type and grade of tumour were determined by chart review, and the findings compared using logistic regression analysis.
RESULTS: Ninety percent of women with early, and 100% with advanced disease reported at least one symptom. With early disease, abdominal pain was reported by 51% and abdominal swelling by 32%, and with advanced disease abdominal swelling by 62% and abdominal pain by 44%. Seventy percent of the early stage and 69% of the advanced stage cohorts reported symptoms of less than 3 months duration. Tumours less than 5 cm diameter were three times more likely to have advanced disease (P = 0.02). Grade 1 tumours were 40 times more likely to be early stage than grade 3 tumours. Serous tumours occurred in 25% of patients with early disease, and 45% with advanced disease (P = 0.01).
CONCLUSION: Patients with early stage ovarian cancer are likely to be younger and to have larger, better differentiated tumours that are more often non-serous histologically. Advanced disease is not invariably due to delayed diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 15904446     DOI: 10.1111/j.1479-828X.2005.00391.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  17 in total

1.  Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort.

Authors:  Alison J Canchola; Ellen T Chang; Leslie Bernstein; Joan A Largent; Peggy Reynolds; Dennis Deapen; Katherine D Henderson; Giske Ursin; Pamela L Horn-Ross
Journal:  Cancer Causes Control       Date:  2010-10-06       Impact factor: 2.506

2.  Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Rayna K Matsuno; Michael E Carney; Marc T Goodman
Journal:  Gynecol Oncol       Date:  2010-06-29       Impact factor: 5.482

3.  Development of a multimarker assay for early detection of ovarian cancer.

Authors:  Zoya Yurkovetsky; Steven Skates; Aleksey Lomakin; Brian Nolen; Trenton Pulsipher; Francesmary Modugno; Jeffrey Marks; Andrew Godwin; Elieser Gorelik; Ian Jacobs; Usha Menon; Karen Lu; Donna Badgwell; Robert C Bast; Anna E Lokshin
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

4.  Predictive value of symptoms for early detection of ovarian cancer.

Authors:  Mary Anne Rossing; Kristine G Wicklund; Kara L Cushing-Haugen; Noel S Weiss
Journal:  J Natl Cancer Inst       Date:  2010-01-28       Impact factor: 13.506

5.  The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.

Authors:  Zehra Nihal Dolgun; Canan Kabaca; Ateş Karateke; Cem İyibozkurt; Cihan İnan; Ahmet Salih Altıntaş; Cihan Karadağ
Journal:  Balkan Med J       Date:  2017-04-05       Impact factor: 2.021

6.  The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.

Authors:  Kimberly A Lowe; M Robyn Andersen; Nicole Urban; Pamela Paley; Charles W Dresher; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2009-05-07       Impact factor: 5.482

7.  A hospital-based case-control study of identifying ovarian cancer using symptom index.

Authors:  Mi-Kyung Kim; Kidong Kim; Sun Min Kim; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

8.  Prediagnostic symptoms of ovarian carcinoma: a case-control study.

Authors:  Galina Lurie; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Marc T Goodman
Journal:  Gynecol Oncol       Date:  2009-05-22       Impact factor: 5.482

9.  Risk of ovarian cancer in women with symptoms in primary care: population based case-control study.

Authors:  William Hamilton; Tim J Peters; Clare Bankhead; Deborah Sharp
Journal:  BMJ       Date:  2009-08-25

10.  Symptoms and risk factors of ovarian cancer: a survey in primary care.

Authors:  Ketan Gajjar; Gemma Ogden; M I Mujahid; Khalil Razvi
Journal:  ISRN Obstet Gynecol       Date:  2012-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.